Real-time enrollment status for this microdeletion 3q29 syndrome clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 6:39 AM UTC
| NCT Number | NCT02447861 |
| Recruiting Status | Recruiting |
| Condition | Microdeletion 3q29 Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 800 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Rutgers, The State University of New Jersey |
| Last Updated on CT.gov | May 20, 2026 (May 20, 2026) |
As of July 19, 2026: Clinical trial NCT02447861 is currently recruiting participants. This clinical trial study for microdeletion 3q29 syndrome is actively seeking new participants at 1 location across the United States. The study is sponsored by Rutgers, The State University of New Jersey. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02447861 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02447861 was last updated May 20, 2026 (May 20, 2026). HelloStudys verifies this status automatically.